Hong Zhang1,2, Yang Xiao2, Rianne Nederlof3, Diane Bakker2, Pengbo Zhang1, Stephen E Girardin4, Markus W Hollmann2, Nina C Weber2, Sander M Houten5, Michel van Weeghel6, Richard G Kibbey7, Coert J Zuurbier2. 1. Department of Anesthesiology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 2. Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands. 3. Institut für Herz-und Kreislaufphysiologie, Heinrich-Heine Universität, Dusseldorf, Germany. 4. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. 5. Icahn Institute for Data Science and Genomic Technology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States. 6. Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology & Metabolism, Amsterdam, Netherlands. 7. Department of Cellular & Molecular Physiology, Yale University School of Medicine, New Haven, CT, United States.
Abstract
Background: NOD-like receptors (NLR) are intracellular sensors of the innate immune system, with the NLRP3 being a pro-inflammatory member that modulates cardiac ischemia-reperfusion injury (IRI) and metabolism. No information is available on a possible role of anti-inflammatory NLRs on IRI and metabolism in the intact heart. Here we hypothesize that the constitutively expressed, anti-inflammatory mitochondrial NLRX1, affects IRI and metabolism of the isolated mouse heart. Methods: Isolated C57Bl/6J and NLRX1 knock-out (KO) mouse hearts were perfused with a physiological mixture of the essential substrates (lactate, glucose, pyruvate, fatty acid, glutamine) and insulin. For the IRI studies, hearts were subjected to either mild (20 min) or severe (35 min) ischemia and IRI was determined at 60 min reperfusion. Inflammatory mediators (IL-6, TNFα) and survival pathways (mito-HKII, p-Akt, p-AMPK, p-STAT3) were analyzed at 5 min of reperfusion. For the metabolism studies, hearts were perfused for 35 min with either 5.5 mM 13C-glucose or 0.4 mM 13C-palmitate under normoxic conditions, followed by LC-MS analysis and integrated, stepwise, mass-isotopomeric flux analysis (MIMOSA). Results: NLRX1 KO significantly increased IRI (infarct size from 63% to 73%, end-diastolic pressure from 59 mmHg to 75 mmHg, and rate-pressure-product recovery from 15% to 6%), following severe, but not mild, ischemia. The increased IRI in NLRX1 KO hearts was associated with depressed Akt signaling at early reperfusion; other survival pathways or inflammatory parameters were not affected. Metabolically, NLRX1 KO hearts displayed increased lactate production and glucose oxidation relative to fatty acid oxidation, associated with increased pyruvate dehydrogenase flux and 10% higher cardiac oxygen consumption. Conclusion: Deletion of the mitochondrially-located NOD-like sensor NLRX1 exacerbates severe cardiac IR injury, possibly through impaired Akt signaling, and increases cardiac glucose metabolism.
Background: NOD-like receptors (NLR) are intracellular sensors of the innate immune system, with the NLRP3 being a pro-inflammatory member that modulates cardiac ischemia-reperfusion injury (IRI) and metabolism. No information is available on a possible role of anti-inflammatory NLRs on IRI and metabolism in the intact heart. Here we hypothesize that the constitutively expressed, anti-inflammatory mitochondrial NLRX1, affects IRI and metabolism of the isolated mouse heart. Methods: Isolated C57Bl/6J and NLRX1 knock-out (KO) mouse hearts were perfused with a physiological mixture of the essential substrates (lactate, glucose, pyruvate, fatty acid, glutamine) and insulin. For the IRI studies, hearts were subjected to either mild (20 min) or severe (35 min) ischemia and IRI was determined at 60 min reperfusion. Inflammatory mediators (IL-6, TNFα) and survival pathways (mito-HKII, p-Akt, p-AMPK, p-STAT3) were analyzed at 5 min of reperfusion. For the metabolism studies, hearts were perfused for 35 min with either 5.5 mM 13C-glucose or 0.4 mM 13C-palmitate under normoxic conditions, followed by LC-MS analysis and integrated, stepwise, mass-isotopomeric flux analysis (MIMOSA). Results: NLRX1 KO significantly increased IRI (infarct size from 63% to 73%, end-diastolic pressure from 59 mmHg to 75 mmHg, and rate-pressure-product recovery from 15% to 6%), following severe, but not mild, ischemia. The increased IRI in NLRX1 KO hearts was associated with depressed Akt signaling at early reperfusion; other survival pathways or inflammatory parameters were not affected. Metabolically, NLRX1 KO hearts displayed increased lactate production and glucose oxidation relative to fatty acid oxidation, associated with increased pyruvate dehydrogenase flux and 10% higher cardiac oxygen consumption. Conclusion: Deletion of the mitochondrially-located NOD-like sensor NLRX1 exacerbates severe cardiac IR injury, possibly through impaired Akt signaling, and increases cardiac glucose metabolism.
Authors: Coert J Zuurbier; Antonio Abbate; Hector A Cabrera-Fuentes; Michael V Cohen; Massimo Collino; Dominique P V De Kleijn; James M Downey; Pasquale Pagliaro; Klaus T Preissner; Masafumi Takahashi; Sean M Davidson Journal: Cardiovasc Res Date: 2019-06-01 Impact factor: 10.787
Authors: Samuel A Killackey; Muhammed A Rahman; Fraser Soares; Ashley B Zhang; Mena Abdel-Nour; Dana J Philpott; Stephen E Girardin Journal: Mol Cell Biochem Date: 2018-09-06 Impact factor: 3.396
Authors: Michael L Blackburn; Kikumi Ono-Moore; Hany F Sobhi; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2020-05-27 Impact factor: 4.310
Authors: Kirsten M A Smeele; Richard Southworth; Rongxue Wu; Chaoqin Xie; Rianne Nederlof; Alice Warley; Jessica K Nelson; Pepijn van Horssen; Jeroen P van den Wijngaard; Sami Heikkinen; Markku Laakso; Anneke Koeman; Maria Siebes; Otto Eerbeek; Fadi G Akar; Hossein Ardehali; Markus W Hollmann; Coert J Zuurbier Journal: Circ Res Date: 2011-04-28 Impact factor: 17.367
Authors: Tiago C Alves; Rebecca L Pongratz; Xiaojian Zhao; Orlando Yarborough; Sam Sereda; Orian Shirihai; Gary W Cline; Graeme Mason; Richard G Kibbey Journal: Cell Metab Date: 2015-09-24 Impact factor: 27.287
Authors: Robert M Smith; Naushaad Suleman; Lydia Lacerda; Lionel H Opie; Shizuo Akira; Kenneth R Chien; Michael N Sack Journal: Cardiovasc Res Date: 2004-09-01 Impact factor: 10.787
Authors: Coert J Zuurbier; Andre Heinen; Anneke Koeman; Roy Stuifbergen; Theodorus B M Hakvoort; Nina C Weber; Markus W Hollmann Journal: J Transl Med Date: 2014-11-29 Impact factor: 5.531
Authors: Ntsiki M Held; Eline N Kuipers; Michel van Weeghel; Jan Bert van Klinken; Simone W Denis; Marc Lombès; Ronald J Wanders; Frédéric M Vaz; Patrick C N Rensen; Arthur J Verhoeven; Mariëtte R Boon; Riekelt H Houtkooper Journal: Sci Rep Date: 2018-06-22 Impact factor: 4.379
Authors: Yang Xiao; Karen Yim; Hong Zhang; Diane Bakker; Rianne Nederlof; Jan A M Smeitink; Herma Renkema; Markus W Hollmann; Nina C Weber; Coert J Zuurbier Journal: Cardiovasc Drugs Ther Date: 2021-04-29 Impact factor: 3.727